Purchase Order 36C24826P0112
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the U.S. Department of Veterans Affairs. The contract, awarded on July 31, 2025, covers the procurement of a heart valve for delivery to a facility in Irvine, CA, with an ultimate completion date of October 1, 2025. This...
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 22 for prosthetic emergency heart valves. The contract, awarded on November 6, 2025, with performance in Irvine, California, carries a completion date of December 31, 2025. This award represents a non-set-aside procurement through the Department of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 8 (VISN 8) on November 19, 2025. The contract calls for the delivery of a heart valve product to support veteran healthcare at the specified place of performance in Irvine, California, with an ultimate completion date of December 18, 2026. No set-aside designation was...
- Edwards Lifesciences LLC, a leading manufacturer of advanced cardiovascular medical devices, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 4 (a civilian component of the Department of Veterans Affairs) on October 21, 2025, for transcatheter heart valves. The contract, valued at $34,000, carries no set-aside designation and is scheduled for completion by January 21, 2026. The products will be delivered to the place of performance in Irvine, California....
- Edwards Lifesciences LLC has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 8 (VISN 8) for the procurement of heart valve products. The contract, issued on September 19, 2025, has an ultimate completion date of November 30, 2026, and will be performed in Irvine, California. No set-aside designation was applied to this award. As a subsidiary of Edwards Lifesciences Corporation, the awardee is a recognized leader in cardiovascular medical devices...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, has been awarded a $32,500 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 10 for post-implant cardiovascular medical equipment. The contract, issued on December 3, 2025, carries an ultimate completion date of March 3, 2026, with performance to be conducted in Irvine, California. This award does not include a set-aside designation and represents...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 1 for the procurement of a heart valve. The contract, awarded on July 28, 2025, with an ultimate completion date of October 27, 2025, does not utilize a set-aside designation. Performance will take place in Irvine, California. Edwards Lifesciences LLC serves as the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order for heart valve products by Veterans Integrated Service Network 8, a civilian agency under the Department of Veterans Affairs. This $34,000 contract, with an ultimate completion date of August 25, 2026, represents a single award with no set-aside designation. The purchase order will be fulfilled at the vendor's facility...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical device innovation, was awarded a $32,500 firm fixed-price purchase order by Veterans Integrated Service Network 10 (VISN 10) on August 19, 2025. This contract, which has no set-aside designation, is scheduled for completion by November 17, 2025, and will be performed in Irvine, California. The award supports the U.S. Department of Veterans Affairs' mission to provide advanced medical...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network 4 for a Transcatheter Heart Valve System valued at $34,000. The contract, awarded on November 18, 2025, with an ultimate completion date of November 18, 2026, represents a no-set-aside procurement supporting the Department of Veterans Affairs' mission to deliver advanced...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network 8 (VISN 8) for heart valve products valued at $34,000. The contract, awarded on October 23, 2025, carries an ultimate completion date of November 30, 2025, with performance taking place in Irvine, California. This award represents a direct procurement with no set-aside designation, reflecting Edwards Lifesciences LLC's position as the sole manufacturer of specialized cardiac devices required by the Veterans Affairs system. This purchase order supports the VA's cardiovascular care capabilities by procuring specialized heart valve products for veteran patients across VISN 8. Edwards Lifesciences LLC maintains a significant presence within the VA healthcare system through multiple contract vehicles, including two large indefinite delivery contracts valued at $2.5 million and $1.25 million respectively, which provide access to advanced transcatheter heart valves and mitral annuloplasty systems. As a self-certified small disadvantaged business, the company plays a critical role in delivering innovative cardiovascular technologies that enable the VA to provide advanced surgical options for structural heart disease treatment to the veteran population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 10/23/25 |